B. R. Celli (Wellesley, United States of America)
Early treatment hastens recovery of COPD exacerbations
T. M. A. Wilkinson, J. R. Hurst, G. C. Donaldson, J. A. Wedzicha (London, United Kingdom)
|  |
First recognition of COPD at the emergency department
I. Cerveri, M. C. Zoia, S. Colato, A. Corsico, M. Beccaria, P. Fulgoni, M. A. Bressan, R. Guarnone, L. Zambianchi, R. Testi, E. Pozzi (Pavia, Verona, Italy)
| |
Airway clearance in bronchiectasis: a randomised crossover trial of ACBT versus TIRE
J. E. Patterson, J. M. Bradley, S. Elborn (Jordanstown, Belfast, United Kingdom)
| |
Reducing exacerbations leads to a better health-related quality of life in patients with COPD
P. W. Jones, E. Ståhl (London, United Kingdom; Lund, Sweden)
| |
COPD exacerbations are reduced by budesonide/formoterol in a single inhaler
P. M. A. Calverley, P. Kuna, H. Olsson (Liverpool, United Kingdom; , Poland; Lund, Sweden)
| |
Symptoms, but not PEF, change during an exacerbation in COPD
R. Pauwels, C. G. Löfdahl, K. Svensson, L. G. Carlsson, E. Ståhl (Ghent, Belgium; Lund, Sweden)
| |
Circumstances of hospital deaths of asthma and /or COPD patients
K. L. May (Warsaw, Poland)
| |
Nonsmoker women with hypercapnic respiratory failure: a prospective study
K. Vaporidi, I. Mitrouska, A. Patrianakos, G. Maltezakis, M. Klimathianaki, P. Vardas, N. M. Siafakas (Heraklion, Greece)
| |
Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
L. V. Koukol, S. A. Pupyshev, B. I. Gelzer, N. M. Kondrashova (Vladivostok, Russia)
| |
The relationship of sinusitis with acute exacerbations of COPD and acute asthmatic attack
T. Kalcioglu, M. Gokirmak, C. Hasanoglu, O. Ozturan, S. Demirel (Malatya, Turkey)
| |
Informative drop out in COPD studies. Investigation of health status of withdrawals in the TRISTAN study
P. W. Jones, J. Vestbo, R. A. Pauwels, P. M. A. Calverley, J. A. Anderson, M. D. Spencer (London, Liverpool, Greenford, United Kingdom; Hvidovre, Denmark; Ghent, Belgium)
| |
Changes in lung function in acute COPD
S. C. Bourne, B. Green, A. M. McMahon, T. Cumberbatch, O. Elsworth, J. W. Millar, S. D. Crowther (Poole, United Kingdom)
| |
Causes of acute exacerbation of chronic obstructive pulmonary disease (COPD) in a hospital in Bucharest
A. M. V. Trailescu, O. I. Nicolaescu (Bucharest, Romania)
| |
Comparison of the different dyspnoea scales in patients with chronic obstructive pulmonary disease
S. ozalevli, E. S. Ucan, D. Ilgin (Izmir, Turkey)
| |
pH in exhaled breath condensate of patients with inflammatory airway diseases
E. K. Anaev, S. N. Avdeev, A. G. Chuchalin (Moscow, Russia)
| |
Relationship between dyspnea levels and health-related quality of life (HRQoL) in patients with stable chronic obstructive pulmonary disease (COPD)
G. K. Efremidis, G. P. Trakada, M. S. Tsiamita, K. V. Spiropoulos (Patras, Greece)
| |
Validity and reliability of the Korean version of the St George's respiratory questionnaire: pilot study
Y. S. Kim, J. W. Moon, M. S. Park, J. H. Chung, S. M. Kwak, S. K. Kim, J. Chang, S. K. Kim (Seoul, Kyung-Ki Do, South Korea)
| |
Montelukast as add-on therapy in severe noninfectious COPD exacerbations
I. O. Agache, L. Eftimie, L. Andrei (Brasov, Romania)
| |
The peculiarities of current chronic obstructive pulmonary disease among women of Taymir
A. F. Kolpakova (Krasnoyarsk, Russia)
| |
Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD)
N. N. Makaryants, A. E. Ergeshov, I. E. Stepanyan, E. I. Shmelev (Moscow, Russia)
| |